Methods of inhibiting leukotriene, treating asthma and treating inflammation
US11001597B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 29, 2020 |
| Grant date | May 11, 2021 |
| Priority date | — |
| Expiry date | Feb 29, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/424
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting leukotriene, treating asthma, or treating inflammation includes: administrating to a subject a therapeutically effective amount of a compound of chemical formula I or II: or a pharmaceutical acceptable salt thereof. R1, R2, R3, and R4 are independently H, halogen, nitro, hydroxyl, cyano, benzyloxy, C1-C8 straight or branched alkyl, C1-C8 straight or branched haloalkyl, C1-C8 straight or branched alkoxy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.